Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Arterio-venous metabolomics exploration reveals major changes across liver and intestine in the obese Yucatan minipig

N. Poupin; M. Tremblay-Franco; A. Amiel; C. Canlet; D. Rémond; L. Debrauwer; D. Dardevet; I. Thiele; M. K. Aurich; F. Jourdan; I. Savary-Auzeloux; S. Polakof Arterio-venous metabolomics exploration reveals major changes across liver and intestine in the obese Yucatan minipig Sci Rep
Insulin Resistance & Diabetes

NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity

C. Pellegrini; M. Fornai; L. Benvenuti; R. Colucci; V. Caputi; P. Palazon-Riquelme; M. C. Giron; A. Nericcio; F. Garelli; V. D'Antongiovanni; C. Segnani; C. Ippolito; M. Nannipieri; G. Lopez-Castejon; P. Pelegrin; G. Haskó; N. Bernardini; C. Blandizzi; L. NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity Br J Pharmacol

Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice

N. M. Pathak; P. J. B. Millar; V. Pathak; P. R. Flatt; V. A. Gault Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice Mol Cell Endocrinol
Cholesterol Insulin Resistance & Diabetes

Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice

V. Pathak; V. A. Gault; P. R. Flatt; N. Irwin Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice Mol Cell Endocrinol
Appetite & Satiety Insulin Resistance & Diabetes

Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice

V. Parthsarathy; C. Hogg; P. R. Flatt; F. P. M. O'Harte Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice Diabetes Obes Metab
Cholesterol Insulin Resistance & Diabetes

Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice

F. P. M. O'Harte; V. Parthsarathy; C. Hogg; P. R. Flatt Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice PLoS One
Insulin Resistance & Diabetes

Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice

O. O. Ojo; D. K. Srinivasan; B. O. Owolabi; J. M. Conlon; P. R. Flatt; Y. H. A. Abdel-Wahab Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice Biochim Biophys Acta
Insulin Resistance & Diabetes

Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study

V. Musale; R. C. Moffett; J. M. Conlon; P. R. Flatt; Y. H. Abdel-Wahab Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study
Genetics Insulin Resistance & Diabetes

Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice

L. M. McShane; N. Irwin; D. O'Flynn; Z. J. Franklin; C. M. Hewage; F. P. O'Harte Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice J Endocrinol
Insulin Resistance & Diabetes

Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease

W. P. Martin; Y. H. D. Chuah; M. Abdelaal; A. Pedersen; D. Malmodin; S. Abrahamsson; M. Hutter; C. Godson; E. P. Brennan; L. Fändriks; C. W. le Roux; N. G. Docherty Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease Front Endocrinol (Lausanne)
Chronic Kidney Disease Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page50 Page51 Page52 … Page54 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2025 ASOI